After its public debut, Imprivata shares rose from the initial price of $15 to $15.25, according to the report.
Imprivata recorded $76 million in sales during the year ended March 31, 2014, according to NASDAQ.
More Articles on IPOs:
Freestanding ER Operator Announces IPO
Imprivata Announces $92M IPO
Castlight Health Revenue Up 339% in Q1